Prolong™ Climax Control Training Program

No prescription or order note from your doctor / therapist is necessary.

Prolong™ was created and approved to be an 'Over-The-Counter' treatment meaning anyone over the age of 18 is able to buy and use the Prolong Device to treat their premature ejaculation.

Absolutely,

Our clinical trials encompassed individuals from diverse backgrounds, representing various walks of life. The only common thread among them was the challenge they faced with premature ejaculation.

Our revolutionary device and 6 week training program have not only withstood rigorous peer review but have also emerged as the unequivocal Gold Standard treatment due to the incredible results.

In contrast to mere 'quick fixes' like delay creams or pills, our device offers an unparalleled solution. What sets it apart even further is its distinction as the sole premature ejaculation treatment granted FDA's prestigious De Novo classification.

This is one of the most common questions we get asked.

The straightforward explanation is that it won't enhance your climax control in the slightest.

The Prolong Device underwent extensive testing, exploring various power levels, vibration patterns, and designs. After rigorous evaluation, we selected the most effective configuration. Furthermore, the device's distinctive patented design significantly influences the distribution and sensation of vibrations.

An effect size is a statistical calculation that can be used to compare the efficacy of different agents by quantifying the size of the difference between treatments. It is a dimensionless measure of the difference in outcomes under two different treatment interventions. Effect sizes thus inform clinicians about the magnitude of treatment effects.

See more here.

(Prolong measured at 0.8 which is considerably higher than anything else available)

Prolong™ is regulated by different bodies around the world.

In the U.S, it’s regulated by a little federal agency you may have heard of - the FDA (Food and Drug Administration).

Prolong is regulated by the FDA’s Center for Devices and Radiological Health (CDRH), which is responsible for regulating firms who manufacture, repackage, re-label and/or import medical devices sold in the United States.

In order to get clearance to market, we had to provide clinical performance data - AKA, a clinical trial. Independent trials were conducted in accordance with FDA’s Investigational Device Exemption (IDE)7 regulation. (And the results were pretty impressive.)

In Europe, we have an MDR (Medical Device Regulation) and in the United Kingdom, our device is cleared by the MHRA (Medicines & Healthcare Regulatory Agency).

Unlike freely available products that merely bear a CE mark and claim to treat PE, our unique selling proposition (USP) lies in being a clinically proven, rigorously regulated treatment that has undergone extensive years of scientific trials.

We are constantly working around the clock to gain regulatory approval to provide Prolong™ in other markets too.

Permanently.

The Prolong™ Device is a permanent solution to premature ejaculation and our clinical trials include a follow up with the participants at 3 and 6 months after their initial 6 week training - We're pleased to say that participants were still seeing further increases and improvements in their ELT (Ejaculation latency time).